Published • loading... • Updated
'Significant price reduction' for Mounjaro means the drug may be deemed cost-effective
Summary by The Journal
1 Articles
1 Articles
'Significant price reduction' for Mounjaro means the drug may be deemed cost-effective
Manufacturer Eli Lilly has offered a price reduction that may mean the medicine will be deemed cost-effective, according to Michael Barry of the National Centre for Pharmacoeconomics.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
